Mentice to Acquire Vascular Simulations
Combined portfolio will enhance Mentice’s endovascular simulation offerings with world class replication solutions. Acquisition to expand Mentice’s global customer base and offer a strong entry into previously untapped market segments.Mentice AB (STO: MNTC) today signed a definitive agreement to acquire the New York-based medical technology company Vascular Simulations (VSI), a world-leading provider of replication solutions allowing endovascular procedures to be performed by doctors manipulating real medical devices within a physical 3D structure that replicates the vessel structure of
